70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop
Toward the end of trading Friday, the Dow traded up 0.42% to 36,071.48 while the NASDAQ rose 0.84% to 15,835.89. The S&P also rose, gaining 0.61% to 4,677.60.
Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet
Midway through trading Friday, the Dow traded up 0.31% to 36,031.95 while the NASDAQ rose 0.54% to 15,788.64. The S&P also rose, gaining 0.43% to 4,669.15.
Mid-Morning Market Update: Markets Rise; AstraZeneca’s COVID-19 Vaccine Turns Profitable In Third Quarter
Following the market opening Friday, the Dow traded up 0.25% to 36,012.29 while the NASDAQ rose 0.24% to 15,741.23. The S&P also rose, gaining 0.14% to 4,655.99.
JP Morgan Downgrades Acutus Medical to Underweight
JP Morgan analyst Robbie Marcus downgrades Acutus Medical (NASDAQ:AFIB) from Neutral to Underweight.
Canaccord Genuity Maintains Buy on Acutus Medical, Lowers Price Target to $10
Canaccord Genuity analyst William Plovanic maintains Acutus Medical (NASDAQ:AFIB) with a Buy and lowers the price target from $18 to $10.
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
Goldman Sachs Initiates Coverage On Acutus Medical with Neutral Rating, Announces Price Target of $10
Goldman Sachs analyst Amit Hazan initiates coverage on Acutus Medical (NASDAQ:AFIB) with a Neutral rating and announces Price Target of $10.